As of 2025-05-20, the Net Margin of Marinomed Biotech AG (MARI.VI) is -74%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2023-12-31 | -74% |
2022-12-31 | -56.7% |
2021-12-31 | -50.7% |
2020-12-31 | -74% |
2019-12-31 | -117.4% |
2018-12-31 | -259.2% |
2017-12-31 | -49.4% |
2016-12-31 | -75.7% |
- | |
- |